In November 2013, representatives from the country’s various Parkinson treatment team met in Lund for a two-day symposium under the theme “To successfully treat Parkinson’s disease along the way.” The meeting was organized by the Parkinson Academy. Sensidose was one of several sponsors of the meeting and were also offered to participate in an exhibition. As a final point on the agenda on the first day, Sensidose was given the opportunity to provide information about the company Sensidose and MyFID ® / Flexilev ® to the entire group of participants .The Parkinson teams showed great interest for this new treatment option with levodopa and assessed that several patients at their respective clinics would be suitable for this new treatment concept.